home *** CD-ROM | disk | FTP | other *** search
- <text id=89TT2749>
- <title>
- Oct. 23, 1989: Business Notes:AIDS
- </title>
- <history>
- TIME--The Weekly Newsmagazine--1989
- Oct. 23, 1989 Is Government Dead?
- </history>
- <article>
- <source>Time Magazine</source>
- <hdr>
- BUSINESS, Page 71
- Business Notes
- AIDS
- A Painful Price Tag
- </hdr><body>
- <p> The controversy over the high price of AIDS drugs is not
- limited to AZT, the antiviral medication that can cost patients
- as much as $550 a month. AIDS activists are assailing the high
- price of pentamidine, a medication that helps prevent a deadly
- form of pneumonia among people infected with the AIDS virus. The
- drug's manufacturer, Lyphomed of Rosemont, Ill., holds the
- exclusive license for pentamidine (brand name: NebuPent) in the
- U.S., where the drug retails for $110 to $200 for a month's
- supply.
- </p>
- <p> Lyphomed defends its pentamidine price by citing high
- research-and-development costs. The firm announced last June
- that it would make the drug available free of charge to patients
- who have no insurance, but the company is still working out
- details of the program. Last month the People with AIDS Health
- Group, based in New York City, began importing small quantities
- of pentamidine from Britain. Reason: a month's supply of the
- European version, which is made by the French firm
- Rhone-Poulenc, costs just $26.
- </p>
-
- </body></article>
- </text>
-
-